Screening for Chlamydia Trachomatis and Neisseria Gonorrhoeae During Pregnancy: A Health Technology Assessment [Internet]

Ismat Kanga; Dinsie Williams; Todd Hatchette; Stacey Burns MacKinnon; Hyosung Jung; Cody Black; Bernice Tsoi; Francesca Brundisini; Deirdre DeJean; Laura Weeks; Caitlyn Ford; David Kaunelis

Screening for Chlamydia Trachomatis and Neisseria Gonorrhoeae During Pregnancy: A Health Technology Assessment [Internet]

Review

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov.

CADTH Health Technology Assessments.

Authors

Affiliations

¹ CADTH, Ottawa, Ontario
² Nova Scotia Health Authority, Halifax, Nova Scotia
³ PEI Department of Health and Wellness, Charlottetown, Prince Edward Island
⁴ McMaster University, Hamilton, Ontario
⁵ University of Ottawa, Ottawa, Ontario

PMID: 31145563
Bookshelf ID: NBK541801

Excerpt

The purpose of this health technology assessment (HTA) is to conduct a systematic assessment of the clinical effectiveness, safety, cost-effectiveness, and perspectives and experiences of pregnant persons, partners, and health care providers regarding the screening of pregnant persons for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) during pregnancy.

Sections

Publication types

Review

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.